Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $106.4881 (1.54%) ($96.7203 - $108.7098) on Tue. Feb. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 61 | Latest Price | $106.4881(1.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.8% a day on average for past five trading days. | Weekly Trend | ABBV advances 3.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(51%) IVE(49%) IWD(48%) SPLV(48%) | Factors Impacting ABBV price | ABBV will decline at least -1.135% in a week (0% probabilities). VIXM(-18%) TLT(-14%) UUP(-10%) IGOV(-4%) DIA(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 0 () | Intraday Trend | 6% | | | |
|
5 Day Moving Average | $108.1(-1.49%) | 10 Day Moving Average | $109.13(-2.42%) | 20 Day Moving Average | $104(2.39%) | To recent high | -9.7% | To recent low | 20.5% | Market Cap | $187.875b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |